<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The prevalence of <z:mp ids='MP_0002055'>diabetes</z:mp> has been rapidly increasing in world-wide countries </plain></SENT>
<SENT sid="1" pm="."><plain>The dominant cause of mortality in diabetic patients is cardiovascular complications </plain></SENT>
<SENT sid="2" pm="."><plain>Mechanism for the susceptibility of diabetic patients to <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disorders</z:e> remains unclear </plain></SENT>
<SENT sid="3" pm="."><plain>Elevated <z:mp ids='MP_0003674'>oxidative stress</z:mp> was detected in diabetic patients or in animal models </plain></SENT>
<SENT sid="4" pm="."><plain>Mitochondria are one of major sources of reactive oxygen species (ROS) in cells </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> dysfunction and DNA mutations have been detected in diabetic patients </plain></SENT>
<SENT sid="6" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp>-associated <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e>, including <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo>, <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo>, <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e>, and increased levels of advanced glycation end products, glycated and oxidized <z:chebi fb="2" ids="6495">lipoproteins</z:chebi>, are associated with <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Glycated or oxidized <z:chebi fb="2" ids="39026">low density lipoproteins</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi>) impair the activities of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> respiratory chain complex enzymes in vascular endothelial cells (EC) </plain></SENT>
<SENT sid="8" pm="."><plain>Dysfunction in <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> respiration may increase the formation of ROS in mitochondria </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase (NOX) generates ROS in cytosol </plain></SENT>
<SENT sid="10" pm="."><plain>Increased NOX activity was detected in diabetic patients </plain></SENT>
<SENT sid="11" pm="."><plain>Glycated and oxidized <z:chebi fb="15" ids="39026">LDL</z:chebi> increase the expression of NOX and ROS production in EC </plain></SENT>
<SENT sid="12" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp>-associated <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> may lead to <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction, NOX activation and excess ROS production, which results in <z:mp ids='MP_0003674'>oxidative stress</z:mp> and promotes <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disorders</z:e> in diabetic patients </plain></SENT>
<SENT sid="13" pm="."><plain><z:chebi fb="0" ids="35664">Statins</z:chebi>, <z:chebi fb="0" ids="6801">metformin</z:chebi> and <z:chebi fb="0" ids="16366,38695">anthocyanidins</z:chebi> may help to attenuate <z:mp ids='MP_0003674'>oxidative stress</z:mp> in vasculature induced by <z:mp ids='MP_0002055'>diabetes</z:mp>-associated <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> </plain></SENT>
</text></document>